The Venom of Tarantula Cubensis (Theranekron) Reduces Apoptosis and Mitochondrial Oxidative Toxicity Caused by NaIO3–Induced Age-Related Macular Degeneration in Human Retinal Pigment Epithelium Cells

2026

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.37212/jcnos.1979759
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Excessive generations of apoptosis and oxygen free radicals (OFRs) are two main common reasons of age-related macular degeneration (AMD). A homeopathic preparation of the Tarantula Cubensis spider venom is Theranekron (TNE). The antiapoptotic and antioxidant actions of TNE were indicated in different disease models except AMD. We investigated the protective actions of TNE and TRPM2 antagonist (N-(p-amylcinnamoyl) anthranilic acid, ACA) on AMD (sodium iodate [NaIO3])-mediated apoptosis and oxidative toxicity in ARPE-19 cells. The ARPE-19 cells were incubated for 24 h in five primary groups: control, 108 ug/mL TNE, 10 mM NaIO3, NaIO3 + TNE, and NaIO3 + ACA. The NaIO3 treatment increased markers of apoptosis (caspase-3, caspase-8, and caspase-9) and oxidative stress (OFRs and mitochondrial membrane dysfunction), while diminishing cell viability. The treatments of TNE and ACA decreased the NaIO3-induced increases of apoptotic and oxidant markers, although the treatments increased cell viability.In conclusion, TNE and ACA treatments reduced NaIO3-caused oxidative degeneration and apoptosis in the ARPE-19 cells. TNE is a possible treatment for AMD-induced apoptosis and OFR production.